News
Morgan Stanley hired Aftab Shahsingh from UBS to lead industrials services coverage in its investment bank in North America, ...
Morgan Stanley has hired Aftab Shahsingh from UBS to lead industrial services coverage in its investment bank in North ...
The Procter & Gamble Company (NYSE:PG) is one of the most profitable consumer stocks to buy now. UBS analyst Peter Grom ...
Oscar's strong revenue growth, improving profitability, and efficient SG&A management support my positive outlook. Read why ...
We recently published These 10 Stocks Just Lost Their Spark. Oscar Health, Inc. (NYSE:OSCR) is one of the worst-performing ...
Swiss Bank UBS has re-hired Masazumi Toriyama to head its Japanese unit's global banking division, according to an internal ...
Rockefeller Global Family Office said Thursday that it has lured an eight-member advisory team away from UBS. The recruitment ...
UBS said expect beat and raise at AI-exposed companies, but sentiment already leans bullish, while highlighting some U.S.
Investing.com -- UBS has downgraded Orlen SA (PR: PKN) to “sell” from “neutral,” citing limited upside following an over 80% ...
UBS and Wells Fargo have made their own additions in the Northeast, including a Massachusetts duo defecting from Commonwealth ...
Ryan McLaughlin Wood has stepped down as UBS Financial Services' Nashville market director after a three-year run, Nashville Business Journal reports.
9h
Fintel on MSNUBS Downgrades Sarepta Therapeutics (SRPT)Fintel reports that on July 21, 2025, UBS downgraded their outlook for Sarepta Therapeutics (NasdaqGS:SRPT) from Buy to Neutral. Analyst Price Forecast Suggests 274.14% Upside As of July 17, 2025, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results